NCT03886753 Pharmacokinetic (PK) and Pharmacodynamics (PD) Study of Ilera Specific Products Status TERMINATED Phase N/A
NCT03876821 Collect of Cord Blood From Subjects at Risk for Sickle Cell Disease, for the Purpose of Laboratory Research Status COMPLETED Phase N/A
NCT03825341 Hydroxyurea Therapy: Optimizing Access in Pediatric Populations Everywhere Status TERMINATED Phase PHASE2
NCT03815695 A SAD/MAD to Assess the Safety, PK/PD of FT-4202 in Healthy Volunteers and Sickle Cell Disease Patients Status COMPLETED Phase PHASE1
NCT03806452 SIKAMIC (SIklos on Kidney Function and AlbuMInuria Clinical Trial) Status COMPLETED Phase PHASE2
NCT03805581 Defibrotide in Sickle Cell Disease-Related Acute Chest Syndrome Status COMPLETED Phase PHASE2
NCT03786549 Pediatric -Adult Care Transition Program of Patients With Sickle Cell Disease Status RECRUITING Phase NA
NCT03758950 Inhaled Mometasone to Promote Reduction in Vasoocclusive Events 2 Status COMPLETED Phase PHASE2
NCT03745287 A Safety and Efficacy Study Evaluating CTX001 in Subjects With Severe Sickle Cell Disease Status COMPLETED Phase PHASE2/PHASE3
NCT03719729 Rifaximin to Modify the Disease Course in Sickle Cell Disease Status UNKNOWN Phase PHASE2
NCT03715972 Cerebrovascular Reserve and White Matter Disease in Patients with Chronic Anemia Status COMPLETED Phase N/A
NCT03709303 Motivations, Expectations, and Decision-making of Sickle Cell Patients in Clinical Research Status COMPLETED Phase N/A
NCT03708731 Exploring Adherence Monitoring in Sickle Cell Disease Status ACTIVE_NOT_RECRUITING Phase N/A